European Commission - Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics

09 May 2021 |

The European Commission is complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID'. Today's Strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.

Read more at the link below.

RELATED LINKS

About Us
Profile
Board of Directors
Stakeholder Network
Contact

LOGIN